Evidence map›Paper›PMID 41989631›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Gender differences in non-motor symptoms in Parkinson's disease: a multicenter longitudinal study.

Sofia Cuoco, Michela Russo, Marina Picillo, Carlo Ricciardi, Maria Claudia Russillo, Marianna Amboni, Gennarina Arabia, Laura Avanzino, Margherita Canesi, Alessia Catania and 34 more

Abstract readMulticenter Study
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Sofia CuocoDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Neuroscience Section, University of Salerno, Via Allende, 84081, Salerno, Baronissi, Italy.ORCID http://orcid.org/0000-0002-5755-4544
Michela RussoDepartment of Chemical, Material and Industrial Production Engineering, University of Naples FEDERICO II, Naples, Italy.
Marina PicilloDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Neuroscience Section, University of Salerno, Via Allende, 84081, Salerno, Baronissi, Italy.
Carlo RicciardiDepartment of Electrical Engineering and Information Technology, University of Naples FEDERICO II, Naples, Italy.
Maria Claudia RussilloSC Neurologia E Stroke Unit, Ospedale Santa Croce Moncalieri, Turin, Italy.
Marianna AmboniDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Neuroscience Section, University of Salerno, Via Allende, 84081, Salerno, Baronissi, Italy.
Gennarina ArabiaDepartment of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, Catanzaro, Italy.
Laura AvanzinoDepartment of Experimental Medicine (DIMES), Section of Human Physiology, University of Genoa, Genoa, Italy.
Margherita CanesiNeurorehabilitation Unit, Parkinson's Disease and Movement Disorders Center, Moriggia-Pelascini Hospital, Gravedona Ed Uniti, Como, Italy.
Alessia CataniaMedical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.
Roberto CeravoloDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Calogero Edoardo CiceroNeurologic Unit, AOU "Policlinico-San Marco", Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy.
Roberto CiliaDepartment of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Isabel ColangeloMedical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.
Giovanna DatiDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Neuroscience Section, University of Salerno, Via Allende, 84081, Salerno, Baronissi, Italy.
Rosa De MiccoDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Anna De RosaDepartment of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
Alessio Di FonzoIRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.
Roberto EleopraDepartment of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Vincenza FetoniUOS Neurologia P.O. Fatebenefratelli-ASST Fatebenefratelli-Sacco, Milan, Italy.
Barbara GaravagliaMedical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.
Augusta GiglioDepartment of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
Martina GiuntiniDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Federica InvernizziMedical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.
Giulia LazzeriCentro Parkinson E Parkinsonismi, Milan, Italy.
Roberta MarcheseIRCCS Azienda Ospedale Metropolitana, Genoa, Italy.
Alessandra NicolettiNeurologic Unit, AOU "Policlinico-San Marco", Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy.
Claudio PacchettiParkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.
Celeste PanteghiniMedical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.
Manuela PilleriCentro Parkinson E Parkinsonismi, Milan, Italy.
Fabiana Giada RadicatiIRCCS San Raffaele, Rome, Italy.
Chiara RealeMedical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C. Besta", Milan, Italy.
Cesa ScaglioneIRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
Andrea SoricelliIRCCS SYNLAB SDN, Naples, Italy.
Fabrizio StocchiIRCCS San Raffaele, Rome, Italy.
Alessandro TessitoreDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Laura VaccaIRCCS San Raffaele, Rome, Italy.
Maria Antonietta VolontèIRCCS San Raffaele Scientific Institute, Neurology Unit, Milan, Italy.
Graziella VolpiSSD Malattie Endocrine Diabetologia, ASST Fatebenefratelli-Sacco, Milan, Italy.
Roberta ZangagliaParkinson's Disease and Movement Disorders Unit, IRCCS Mondino Foundation, Pavia, Italy.
Francesco AmatoDepartment of Electrical Engineering and Information Technology, University of Naples FEDERICO II, Naples, Italy.
Paolo BaroneDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Neuroscience Section, University of Salerno, Via Allende, 84081, Salerno, Baronissi, Italy.
Maria Teresa PellecchiaDepartment of Medicine, Surgery and Dentistry Scuola Medica Salernitana, Neuroscience Section, University of Salerno, Via Allende, 84081, Salerno, Baronissi, Italy. mpellecchia@unisa.it.ORCID http://orcid.org/0000-0002-6217-313X
SIN Gender Neurology Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-motor symptoms (NMSs) are highly prevalent in Parkinson’s disease (PD) and affect patients’ quality of life. Data on gender differences in NMSs are largely cross-sectional and derived from chronically treated populations. Longitudinal evidence in early, levodopa-naïve PD patients remains limited. This study aims to longitudinally investigate gender differences in a wide range of NMSs in early-stage levodopa-naïve PD patients during the first 2 years following levodopa initiation.

methodsThis multicenter, prospective study enrolled 216 levodopa-naïve PD patients (139 men, 77 women) from 17 Italian movement disorder centers. Patients were evaluated at baseline and after 24 months (24 M) using validated scales. Baseline gender differences were explored using group comparisons. Gender effects at 24 M were examined using ANCOVA models adjusted for baseline values and levodopa dose at follow-up.

resultsAt baseline, women showed greater cardiovascular and thermoregulatory autonomic dysfunction, higher anxiety, pain, fatigue, and worse quality of life, whereas men exhibited greater sexual dysfunction, daytime sleepiness, and better attentional performance. At the 24 M, gender differences persisted only for anxiety, pain, mobility, and emotional well-being, while additional significant differences emerged, including hypersexuality, visuo- spatial domain, and orthostatic-hypotension. Women exhibited greater symptom severity than men across all aforementioned variables, with the exception of hypersexuality.

conclusionsGender significantly influences the expression and early evolution of NMSs in PD, independently of levodopa exposure. Gender-specific NMSs profiles are already evident in the first two years of treatment. These findings highlight the importance of integrating gender considerations into early assessment and personalized management of NMSs in PD.

Indexed as

Parkinson DiseaseSex CharacteristicsAgedAntiparkinson AgentsFemaleHumansLevodopaLongitudinal StudiesMaleMiddle AgedProspective StudiesQuality of LifeSeverity of Illness IndexAntiparkinson AgentsLevodopaEarly-stage Parkinson’s diseaseLevodopa-naïve patientsLongitudinal studyNon-motor disordersSex differences

Identifiers

PMID41989631
PMCPMC13086900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.